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life data. In addition, they consent to broad randomization 
for being offered experimental interventions.  
Within this cohort, patients eligible for boost treatment - 
LARC (T3+/4NxM0 or TxN2M0) located ≤10cm from the anus - 
are included in a sub-cohort. From this sub-cohort, a random 
sample is offered the boost treatment in addition to CRT 
(intervention arm); this offer may be accepted or refused. 
Patients who are not randomly selected to be offered the 
boost intervention undergo standard CRT without further 
study notification (control arm). Data will be analyzed 
according to intention-to-treat. 
The boost intervention consists of 5 x 3Gy to the gross tumor 
volume (without concomitant chemotherapy) delivered 1 
week prior to standard CRT (25 x 2Gy combined with 
capecitabine). 
Results: In the past 6 weeks, of the 10 eligible patients, 9 
consented for cohort participation and gave broad consent 
for randomization. All nine patients were randomized. Four 
patients were allocated to the control arm and received CRT 
without further notification. Five patients were allocated to 
the intervention arm and were offered the boost in addition 
to CRT. Three patients accepted and underwent the boost, 
whereas 2 refused because of personal reasons and 
reluctance to undergo MRI. 
Conclusions: The cmRCT design shows potential to achieve 
high recruitment rates (9 out of 10 patients) and offer 
patients interventions by asking broad consent for 
randomization. If the number of patients refusing the offer 
remains high, the boost effect may be diluted, demanding 
advanced statistical solutions (instrumental variable 
analysis). Updated results will be presented in April 2015.  
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Purpose/Objective: During the past 10 years, the 
mathematical models proposed for converting an EPID signal 
into absorbed dose to water have evolved considerably by 
integrating correction functions of various degrees of 
complexity to take modern conditions of irradiation into 
account. As a whole, these models require prior knowledge of 
mechanical and dosimetric data for the radiation beams so 
that suitable correction factors can be applied. However, in 
spite of all this sophistication, the results obtained show 
discrepancies between the calculated and measured doses 
that may exceed 5% for image pixels that have received an 
equivalent dose lower than 30cGy in water.  
In this work, we propose a new method for calibrating the 
EPID detector which leads to a simple, robust model of the 
detector response to irradiation by X-ray photons, in 
absorbed dose to water. This modelling applies to all pixels 
of the image, without any correcting factor and whatever the 
level of the equivalent dose in water. 
Materials and Methods: Starting from the hypothesis that the 
grey level (GL) read in each pixel of the image is proportional 
to the average dose in water (D) delivered by the irradiating 
beam for each acquisition frame making up the final image 
(D=Dtot/Nbframes; Dtot: total dose delivered by the beam; 
Nbframes: number of acquisition frames), we established a 
simple relation among all these data:  
D = A + B * ln(GL – C) Equation1 
The coefficients A, B and C are obtained by mathematical 
modelling of the pairs of values of D and GL read on the 
central pixel of a set of images called 'calibration images'.  
Results: Applied to each of the 37 'calibration images', 
Equation 1 showed differences of less than 2% between the 
calculated dose and the dose measured in water for the 
central pixel. When this equation was applied, with no 
additional mathematical correction, to all the pixels of the 2-
D image, the results showed that over 95% of the points of 
the image respected a γ–index criterion fixed at 2%/2mm.  
This modelling was also applied to 2-D EPID images obtained 
by simulating VMAT fields and the results satisfied a γ-index 
criterion fixed at 3%/3mm for more than 95% of the points 
analysed. 
Conclusions: Our method allows the EPID to be considered 
and used as a 2-D detector measuring the absolute absorbed 
dose to water.  
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Purpose/Objective: The complexity of modern radiotherapy 
necessitates comprehensive dose validation which has 
motivated research into three dimensional (3D) dosimetry. 
One such dosimetry system is based on polymerization of 
monomers suspended in a gelatin matrix. To verify the 
performance of such a polymer gel dosimetry system we have 
in this study compared its dosimetric precision to that of 
conventional radiochromic films. 
Materials and Methods: A cylindrical normoxic 
polyacrylamide gel (nPAG) dosimeter (Ø15cm x 15cm) and an 
EBT2 radiochromic film dosimeter (15x15cm2) were irradiated 
with a volumetric modulated arc therapy (VMAT) plan. During 
irradiation the film was embedded in the gel dosimeter to 
obtain similar irradiation conditions. The resulting dose 
distribution consisted of a cylindrical shaped dose region with 
a gradient along the cylinder axis from 5 Gy to 0 Gy. The 
dose distributions were subsequently read out using an 
optical CT scanner and a flatbed scanner, respectively, and 
were then compared to the calculated distribution using a 
voxel-to-voxel difference analysis. 
Results: Good agreement was observed between the two 
measurements and the calculated plan as seen in figure 1. A 
slight deviation of the gel measurement was observed at the 
lowest dose. The voxel-to-voxel difference analysis resulted 
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in a standard deviation, i.e. dosimetric precision, of 0.14 Gy 
between the gel and film measurement while differences of 
0.11 Gy for the gel and 0.13 Gy for the film was found when 
comparing to the calculated dose distribution. 
 
 
 
Conclusions: Both gel and film reproduced the delivered 
dose distribution with only small deviations. In addition, the 
gel measurement showed slightly higher dosimetric precision 
than the film when compared to the calculated distribution. 
This study therefore shows that this 3D dosimetry system can 
provide dosimetric precision that is comparable with 
radiochromic film dosimetry. 
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Purpose/Objective: To evaluate and characterize a 
luminescence screen based QA system as implemented in SRS 
treatment field verification of a linac system. 
Materials and Methods: The home-made QA system consists 
of a set of PMMA block, a luminescence screen 
(interchangeable between plastic scintillator and fluorescent 
screen), a CCD camera and a light-tight box. The 
characteristics of fluorescent screen (Kodak, Lanex regular 
screen) and plastic scintillator (Apex, Anthracene with base 
polyvinyltoluene) were quantified on a linac (VARIAN 
TrueBeam). The PMMA block has a size of 30cm x 30cm and 
different build up thickness can be used depending on beam 
energy and the depth of beam profile to be evaluated. 10 cm 
thick PMMA was put behind the screen to ensure enough 
backscatter radiation. The signal light was reflected by a 
mirror below the transparent PMMA to a CCD camera away 
from the PMMA block. Dose linearity was examined on both 
materials by applying a range of MU from 1 to 300 under a 
10cm X 10cm radiation field. After applying a median-filter 
to remove radiation induced noise from the captured image, 
the mean signal of a small ROI (10 cm2) at the centre were 
calculated and correlated with the corresponding doses. The 
system can then be calibrated. Dose rate dependence was 
tested by varying dose rate from 200 MU/Min to 600 MU/Min. 
Energy dependence was also investigated with different 
radiation energies including 6MV and 15MV photon beams and 
6MeV, 9MeV, 12MeV, 16MeV, 20MeV electron beams. Parasitic 
Cherenkov emission signals were eliminated by applying a 
deconvolution kernel on the original signals. Small circular 
field size measurements, from 7.5mm to 30 mm in diameter, 
were done at the appropriate depth. Both inline and crossline 
absolute radiation profiles of the circular fields were then 
obtained. 
Results: The pixel values increase linearly with the delivered 
dose up to 3Gy and a linear regression analysis yields R2 > 
0.99. In this system, the minimum detectable dose is 12 mGy 
for plastic scintillator and 2 mGy for fluorescent screen on 
6MV beam. In dose rate dependence test, plastic scintillator 
has a maximum deviation of 1.3% from 200MU/Min to 600 
MU/Min on 6 MV while fluorescent screen has a maximum 
deviation of 1.1%. Plastic scintillator shows a maximum 
deviation of 4.2% for photon beam energy up to 15MV and 
electron beam energy up to 20MeV. Fluorescent screen shows 
clear energy dependence. The pixel size of the system is 
about 0.26 mm. In small circular field sizes measurement, 
measured dose distributions agree with the data generated 
by TPS. The gamma index passing rate for 7.5mm and 30 mm 
diameter collimator is 98.8% (2% dose difference /1 mm DTA) 
and 99.0 % (2% dose difference /1 mm DTA) respectively. 
 
 
 
Conclusions: The luminescence screen based quality 
assurance system we developed has excellent dose linearity 
and dose rate independence. The system can provide fast and 
precise absolute dose verification of a treatment beam after 
calibration. The high precision characteristic of the system 
makes it valuable for dose verification of small treatment 
beams. 
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